Risk of breast cancer's return looms for 20 years: study

France24, 08 Nov 2017

MIAMI (AFP) - Women who are treated for a kind of breast cancer that is fueled by the hormone estrogen face a substantial risk…

Certains cancers du sein présentent un risque de rechute pendant 20 ans

Yahoo! News, 08 Nov 2017

Des chercheurs ont analysé les données de 63 000 femmes atteintes d'un des cancers du sein les plus courants.

Breast cancer recurrence risk lingers years after treatment ends. ecancer

ecancer, 08 Nov 2017

Even 20 years after a diagnosis, women with a type of breast cancer fueled by oestrogen still face a substantial risk of cancer…

Breast cancer may return even many years after treatment ends: study

China.org, 08 Nov 2017

WASHINGTON, Nov. 8 (Xinhua) -- Women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer…

News story from News and Star on Wednesday 08 November 2017

News and Star, 08 Nov 2017

Risk of breast cancer's return looms for 20 years: Study

The Straits Times, 08 Nov 2017

MIAMI (AFP) - Women who are treated for a kind of breast cancer that is fueled by the hormone oestrogen face a substantial risk…

Breast cancer recurrence risk lingers years after treatment ends

MedicalXpress, 08 Nov 2017

Even 20 years after a diagnosis, women with a type of breast cancer fueled by estrogen still face a substantial risk of cancer…

Breast Cancer Recurrence Risk Lingers Years After Treatment Ends

Newswise, 08 Nov 2017

Return to Article List Steady rates of recurrence in women with estrogen receptor-positive disease could influence decisions…

Oväntad hög återfallsrisk vid bröstcancer

Dagens Medicin, 08 Nov 2017

open Tamoxifen är ett vanligt använt läkemedel som motverkar återfall vid tidig hormonreceptorpositiv bröstcancer.

News story from Chichester Observer on Wednesday 08 November 2017

Chichester Observer, 08 Nov 2017

Breast cancer can resurface 15 years after treatment, research shows

Mid Sussex Times, 08 Nov 2017

Breast cancer can resurface after remaining dormant for 15 years following successful treatment, a study has found.

News story from Rye and Battle Observer on Wednesday 08 November 2017

Rye and Battle Observer, 08 Nov 2017

News story from Shoreham Herald on Wednesday 08 November 2017

Shoreham Herald, 08 Nov 2017

News story from Crawley and Horley Observer on Wednesday 08 November 2017

Crawley and Horley Observer, 08 Nov 2017

News story from The Portsmouth News on Wednesday 08 November 2017

The Portsmouth News, 08 Nov 2017

News story from West Sussex Gazette on Wednesday 08 November 2017

West Sussex Gazette, 08 Nov 2017

News story from Littlehampton Gazette on Wednesday 08 November 2017

Littlehampton Gazette, 08 Nov 2017

News story from Midhurst and Petworth Observer on Wednesday 08 November 2017

Midhurst and Petworth Observer, 08 Nov 2017

News story from Bexhill-on-Sea Observer on Wednesday 08 November 2017

Bexhill-on-Sea Observer, 08 Nov 2017

News story from Eastbourne Herald on Wednesday 08 November 2017

Eastbourne Herald, 08 Nov 2017

Risk of certain breast cancers coming back remains for at least 20 years after treatment

Cancer Research UK, 08 Nov 2017

The risk of a certain type of breast cancer coming back in other parts of the body stays constant for at least 20 years after…

Risk of certain breast cancers coming back remains for at least 20 years after treatment

Bioportfolio, 08 Nov 2017

News report The risk of a certain type of breast cancer coming back in other parts of the body stays constant for at least 20…

Breast cancer study suggests review of treatment length

My Science, 08 Nov 2017

A new study published in the New England Journal of Medicine, funded by Cancer Research UK, has found that the risk of breast…